Impact of the Choice of Gastric Tube Placement Sites on the Incidence of Ventilator Associated Pneumonia

Condition(s) studied

Investigational drug(s) / intervention(s)

nasogastric tube and orogastric tube: nasogastric tube in period 1 and orogastric tube in period 2

orogastric tube and nasogastric tube: orogastric tube in period 1 and nasogastric tube in period 2

Study summary

In intensive care, many gastric tubes are inserted on a regular basis. There are different practices in terms of the location of the gastric tube. In some cases, the tube is inserted through the nose and in others, it is inserted through the mouth.

In the literature and in practice, these gastric tubes create discomfort and complications that have an impact not only on the patient, but also on the treatments and the length of the patient's stay in hospital.

Nosocomial Ventilator Associated Pneumonia is the most serious common complication for patients intubated with a gastric tube. It is possible that placement site may have an impact on the risk of developing Ventilator Associated Pneumonia, particularly by increasing the risk of bacterial pullulation opposite the sinuses when the tube is placed via the nasal route.

Investigator hypothesises that placing the gastric tube orally will reduce the rate of ventilator-associated pneumonia compared with the nasal route in mechanically ventilated intensive care patients.

Eligibility

Primary outcome measure(s)

• Compare impact of insertion site of gastric tube on the incidence of ventilator associated pneumoniae — Day 28
  The impact is measured by the number of ventilator associated peumonia

Trial sites (16)

More Centre Hospitalier le Mans trials in France